By far the worst performer was BLUR:Blur Group, which declared they are burning cash way faster than they are earning it and set out series of measures to try and save the company. The share price tanked and the value of my holding went down 18%. It's now down 99% from my purchase price and worth £1 but thank goodness I bought it when I didn't have a scooby what I was doing and am only losing £108.
No other double-digit losers, but some troubling and expensive losers. JLP:Jubilee Platinum dropped back below 4p and lost 9% of their value, which is very disappointing given the potential of the company. However, when the BoD just keep shooting themselves in the foot, it's not that surprising. News on Hernic earnings should see this turn around.
RDT:Rosslyn Data dropped 8% and is now losing 82% of the purchase value and is worth just £68, losing £307. This was a toe-dip and I'm glad it was only that.
CAML:Central Asia Metals had a bad week, losing 6% but still up by 30%, making £1,022 profit and having dished out an additional £473 in dividends. What a company!
Nemesis Share OPTI:Optibiotix finished the week on the same price as it started, but my purchase at 66.7p was below the 68p closing bid price, so my purchase this week has cleared spread and commission.
There were a few double-digit risers this week. TND:Tandem Group have been stagnated for a long time, but climbed 13% this week after a very strong AGM statement. With only 4.7 million shares in issue, these are staggeringly illiquid and so when they move up or down it tends to be quite extreme. They are still 27% down and losing £297 so I'll be watching them with interest for a while yet.
There's no point trying to bet on Share of the Week. Nothing else came remotely close to the 20% rise in value in my ISA account of Star Share IQE:IQE. These are up by 187% now and making £3,664 paper profit, and the SIPP holding is making £2,119 paper profit. Stunning! If it wasn't for IQE my combined portfolios would be well in the red! If I sold them all now and made £5,700 profit I wouldn't have to sell anything else for ages, but they've only just started so if anything I should be buying more.
A slight narrowing of the gap, but it's not bad.
The combined ISA and share accounts look like this
| Weekly Change | |||
| Portfolio cost | £45,614.89 | +£2,275.08 | |
| Portfolio sell value (bid price - commission) | £46,336.05 | (1.6%) | -£589.25 |
| Potential profits | £6,976.08 | +£183.13 | |
| Yr 2 Dividends | £486.29 | +£0 | |
| Yr 2 Profit from sales | £2,401.06 | +£0 | |
| Yr 2 Average monthly cash profit | £268.46 | (7.1%) | -£5.97 |
| Total Dividends | £1,154.22 | +£0 | |
| Total Profit from sales | £6.241.32 | +£0 | |
| Average monthly cash profit | £322.69 | (8.5%) | -£3.32 |
| (Sold stocks profit + Dividends - Fees / Months) |
Big jump in cost thanks to my bank loan to fund a last purchase (honest) of OPTI:Optibiotix and take them to 30% of my holding. Potential profits actually increased thanks to IQE:IQE but a combination of reducing profits elsewhere and deepening losses meant a £589 reduction in value. With the portfolio value climbing so much, there was a bigger than usual impact on the performance percentage, now 1.5% below target of 10%.
Just about stays in the black, but way too close for comfort.
The SIPP looks like this after week 82
| Weekly Change | |||
| Portfolio cost | £17,853.50 | +£0 | |
| Portfolio sell value (bid price - commission) | £20,146.31 | (12.8%) | -£12.70 |
| Potential profits | £3,581.19 | +£96.20 | |
| Yr 2 Dividends | £294.96 | +£0 | |
| Yr 2 Profit from sales | £1,596.81 | +£0 | |
| Yr 2 Average monthly cash profit | £265.96 | (17.9%) | -£9.17 |
| Total Dividends | £708.15 | +£0 | |
| Total Profit from sales | £3,946.67 | +£0 | |
| Average monthly cash profit | £240.64 | (16.2%) | -£2.97 |
| (Sold stocks profit + Dividends - Fees / Months) |
As with the other accounts, the profits are up thanks to IQE:IQE but most of the gain is lost by CAML:Central Asia Metals dropping and with deepening losses elsewhere, the overall effect is a £12 drop in value. Performance is still more than acceptable with year 2 still ahead of long-term average.
A consolidation week I think.
Oh must I? OK - here's the horrid trading account after week 48
| Weekly Change | |||
| Portfolio cost | £486.05 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £335.55 | (-30.8%) | +£13.90 |
| Potential profits | £0 | +£0 | |
| Dividends | £0 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£2.06 | (-5.1%) | +£0.05 |
| (Sold stocks profit + Dividends - Fees / Months) |
Almost a year now and a complete pile of poo. REDS:RedstoneConnect recovered last week's losses but is showing no sign of the meteoric climb I thought was on the cards when I first bought them. I'm ashamed to admit that I fell for a load of ramping hype on the bulletin board - let that be a harsh lesson!
This share has saved me making other mistakes though - I was all enthused by TRIN:Trinity after it had whizzed up over a few days from about 12p to 20p. The bulletin board was full of enthusiasm, but remembering my experience with REDS:RedstoneConnect I watched instead of leaping in. It's now trading at 10.75p. Ouch!
Pants!
I don't know of anything particularly interesting due to happen next week. My main hope is that OPTI:Optibiotix will stage an amazing turnaround, coz then I'll look dead good for having bought more shares with my new loan while they were rock-bottom.
If they drop further then I'll look like a tit.
I wonder what's more likely?...
No comments:
Post a Comment